Home Latest Drug News News Blog Takeda could face thousands of lawsuits over Actos' alleged cancer link
Bloomberg News (12/1, Feeley) reported, Takeda Pharmaceutical Co. "may face as many as 10,000 lawsuits in US courts over allegations that its Actos [pioglitazone] diabetes drug causes bladder cancer, and a group of judges is preparing to decide where they should be consolidated." Several months ago, "US regulators found...that an analysis of a company-sponsored study showed some users of Actos, the world's best-selling diabetes medication, faced an increased risk of developing the potentially fatal disease." Bloomberg News adds that lawyers representing claimants assert that "The evidence linking Actos to bladder cancer "is unusually strong and clear."
 
Have You Been Injured?
Free Claim Review
If you or a loved one have suffered a serious injury or side effect related to drug or supplement, please contact us for a free and confidential case review.
 

 

 

 

 

 

 

 

 



 

 

 

 

 

  
 
 
Polls
Do You Think The FDA Is Doing Enough To Protect Consumers?
 
Facebook MySpace Twitter Digg Delicious Stumbleupon Google Bookmarks RSS Feed